CLINICAL RESEARCH IN EMERGENCY MEDICINE
Professor Daniel Fatovich, Emergency physician and clinical researcher
Royal Perth Hospital Emergency Department &
Head of the Centre for Clinical Research in Emergency Medicine (CCREM)
Harry Perkins Institute of Medical Research &
Clinical Professor, UWA Medical School, Emergency Medicine
University of Western Australia, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | September 2025
Professor Daniel Fatovich is a senior emergency physician and clinical researcher at Royal Perth Hospital Emergency Department (ED), with over 30 years’ experience in the design and conduct of clinical research in Emergency Medicine. He is also Head of the Centre for Clinical Research in Emergency Medicine (CCREM) within the Harry Perkins Institute of Medical Research.
He is Professor of Emergency Medicine, University of Western Australia; Director of Research for East Metropolitan Health Service (EMHS), providing strategic advice and leadership; Board Member of the Royal Perth Hospital Research Foundation; Chair of the EMHS Research Advisory Committee.
Professor Fatovich was an inaugural executive member of the Australasian College for Emergency Medicine (ACEM) Research Committee (2019-2024) and the Clinical Trials Network (2018-2024) and has received over $33m in competitive grant funding.
In 2020 and 2023, he was Ministerial adviser for the passage of the Guardianship and Administration (Medical Research) Act Western Australia. In 2017-18, he was deputy chair of the WA Methamphetamine Taskforce. He is chief investigator for the Emerging Drugs Network of Australia (EDNA), which he describes as the most fabulous project of his career. This is best exemplified by a famous quote from Victor Hugo: there is nothing so powerful as an idea whose time has come. EDNA is a national toxico-surveillance system for detecting illicit, emerging and novel psychoactive substances, in presentations to sentinel Emergency Departments. In 2024, EDNA won a WA Health Excellence Award for Excellence in Research and Innovation, and the 2024 UWA Vice-Chancellor’s Award in Research Impact and Innovation.
Expertscape ranks him in the top 1% globally for expertise in Emergency Medicine. He loves to challenge doctors to think, and to think differently.
Source: Supplied
-
New models of care and value in General Practice
Dr Michael Wright is a GP, health economist and health services researcher. Dr Wright currently works as a portfolio GP, combining clinical practice with strategic appointments (most recently with RACGP, Central and Eastern Sydney Primary Health Network, Avant Mutual the Australian Institute of Health and Welfare) and academic research analysing the effects of current health policy on the quality and performance of primary care.
-
Role of metabolic dysfunction in advanced prostate cancer
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.
-
Metabolic phenotyping, lipidomics & bioinformatics in dementia
Dr Luke Whiley is a dementia researcher whose work focuses on understanding how the body’s metabolism, particularly the biology of fats known as lipids, influences our health throughout ageing.
His research explores how the body responds to illness, lifestyle, and environmental stress at a chemical level, and how these responses shape longterm disease risk. Using advanced blood-based measurement technologies, Dr Whiley studies thousands of small molecules at once to build a snapshot of a person’s metabolic health. By combining these measurements with data science approaches, his work identifies biological pathways that become disrupted in disease, providing insight into why some people are more vulnerable to conditions such as dementia.
